A Proof of Concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma
Condition: GlioblastomaInterventions: Drug: Temozolomide; Drug: Aprepitant; Drug: Minocycline; Drug: Disulfiram; Drug: Celecoxib; Drug: Sertraline; Drug: Captopril; Drug: Itraconazole; Drug: Ritonavir; Drug: AuranofinSponsors: University of Ulm; Reliable Cancer Therapies; Anticancer Fund, BelgiumNot yet recruiting - verified May 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 14, 2016 Category: Research Source Type: clinical trials
A Proof of Concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma
Condition: GlioblastomaInterventions: Drug: Temozolomide; Drug: Aprepitant; Drug: Minocycline; Drug: Disulfiram; Drug: Celecoxib; Drug: Sertraline; Drug: Captopril; Drug: Itraconazole; Drug: Ritonavir; Drug: AuranofinSponsor: University of UlmNot yet recruiting - verified May 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 14, 2016 Category: Research Source Type: clinical trials
A Proof of Concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma
Condition: GlioblastomaInterventions: Drug: Temozolomide; Drug: Aprepitant; Drug: Minocycline; Drug: Disulfiram; Drug: Celecoxib; Drug: Sertraline; Drug: Captopril; Drug: Itraconazole; Drug: Ritonavir; Drug: AuranofinSponsors: University of Ulm; Reliable Cancer Therapies; Anticancer Fund, BelgiumNot yet recruiting - verified May 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 14, 2016 Category: Research Source Type: clinical trials